Prof. Dr. Christine Skerka

Alumni

Publikationen

Halder LD, Babych S, Palme DI, Mansouri-Ghahnavieh E, Ivanov L, Ashonibare V, Langenhorst D, Prusty B, Rambach G, Wich M, Trinks N, Blango MG, Kornitzer D, Terpitz U, Speth C, Jungnickel B, Beyersdorf N, Zipfel PF, Brakhage AA, Skerka C (2022) Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth. mBio 13(1), e0356321.
Shahraz A, Lin Y, Mbroh J, Winkler J, Liao H, Lackmann M, Bungartz A, Zipfel PF, Skerka C, Neumann H (2022) Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway. Sci Rep 12(1), 5818.
Stea ED, Skerka C, Accetturo M, Pesce F, Wiech T, Hartmann A, Pontrelli P, Castellano G, Zipfel PF, Gesualdo L (2022) Novel FHR2 variants in atypical haemolytic uremic syndrome: a case study of translational medicine approach in renal transplantation. Front Immunol [Accepted]
Zipfel PF, Skerka C (2022) From magic bullets to modern therapeutics: Paul Ehrlich, the German immunobiologist and physician who coined the term ‘Complement’. Mol Immunol 150, 90-98.
Dasari P, Nordengrün M, Vilhena C, Steil L, Abdurrahman G, Surmann K, Dhople V, Lahrberg J, Bachert C, Skerka C, Völker U, Bröker B M, Zipfel P F (2021) The protease SplB of Staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis. J Bacteriol 204(1), e0018421.
Du S, Vilhena C, King S, Sahagún-Ruiz A, Hammerschmidt S, Skerka C, Zipfel PF (2021) Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic. Sci Rep 11(1), 1701.
Irmscher S, Zipfel SLH, Halder LD, Ivanov L, Gonzalez-Delgado A, Waldeyer C, Seiffert M, Brunner FJ, von der Heide M, Löschmann I, Wulf S, Czamara D, Papac-Milicevic N, Strauß O, Lorkowski S, Reichenspurner H, Holers MV, Banda NK, Zeller T, Binder EB, Binder CJ, Wiech T, Zipfel PF, Skerka C (2021) Factor H-related protein 1 (FHR-1) is associated with atherosclerotic cardiovascular disease. Sci Rep 11(1), 22511.
Zipfel PF , Wiech T, Gröne HJ, Skerka C (2021) Complement catalyzing glomerular diseases. Cell Tissue Res 385(2), 355-370. (Review)
Alic L, Papac-Milicevic N, Czamara D, Rudnick RB, Ozsvar-Kozma M, Hartmann A, Gurbisz M, Hoermann G, Haslinger-Hutter S, Zipfel PF, Skerka C, Binder EB, Binder CJ (2020) A genome-wide association study identifies key modulators of complement factor h binding to malondialdehyde-epitopes. Proc Nat Acad Sci USA 117(18), 9942-9951.
Hackl A, Erger F, Skerka C, Wenzel A, Tschernoster N, Ehren R, Burgmaier K, Riehmer V, Kirschfink M, Weber lT, Altmueller J, Zipfel PF, Habbig S (2020) Long-term data on two sisters with C3GN due to an identical, homozygous CFH mutation and autoantibodies. Clini Nephrol 94(4), 197-206.